Difference between revisions of "Urinary bladder"

From Libre Pathology
Jump to navigation Jump to search
Line 40: Line 40:


==Urachal carcinoma==
==Urachal carcinoma==
===General===
{{Main|Urachal carcinoma}}
*Very rare<ref name=pmid16826585>{{Cite journal  | last1 = Ashley | first1 = RA. | last2 = Inman | first2 = BA. | last3 = Sebo | first3 = TJ. | last4 = Leibovich | first4 = BC. | last5 = Blute | first5 = ML. | last6 = Kwon | first6 = ED. | last7 = Zincke | first7 = H. | title = Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. | journal = Cancer | volume = 107 | issue = 4 | pages = 712-20 | month = Aug | year = 2006 | doi = 10.1002/cncr.22060 | PMID = 16826585 }}</ref>~ 0.2% of bladder cancers.<ref name=pmid22901574>{{Cite journal  | last1 = Bruins | first1 = HM. | last2 = Visser | first2 = O. | last3 = Ploeg | first3 = M. | last4 = Hulsbergen-van de Kaa | first4 = CA. | last5 = Kiemeney | first5 = LA. | last6 = Witjes | first6 = JA. | title = The clinical epidemiology of urachal carcinoma: results of a large, population based study. | journal = J Urol | volume = 188 | issue = 4 | pages = 1102-7 | month = Oct | year = 2012 | doi = 10.1016/j.juro.2012.06.020 | PMID = 22901574 }}</ref>
*Younger <55 years-old.
 
Treatment:
*Partial cystectomy +/- umbilectomy.
 
===Gross===
*Lesion must be in urachus or dome of urinary bladder.
 
===Microscopic===
Features:
*Usually adenocarcinoma.
*Adjacent urothelium typically benign.
 
DDx:<ref name=Ref_Amin2-143>{{Ref Amin|2-143}}</ref>
*[[Adenocarcinoma of the urinary bladder]].
*Invasive [[urothelial carcinoma]] with glandular differentiation.
*Metastatic adenocarcinoma/adenocarcinoma extending from another structure, e.g. [[colorectal adenocarcinoma]].
 
====Patterns====
*Enteric - looks like colonic adenocarcinoma.
*Mucinous.
*Signet ring.
 
Note:
*Urachal carcinoma may be ''nonglandular''.<ref name=pmid22301493>{{Cite journal  | last1 = Paner | first1 = GP. | last2 = Barkan | first2 = GA. | last3 = Mehta | first3 = V. | last4 = Sirintrapun | first4 = SJ. | last5 = Tsuzuki | first5 = T. | last6 = Sebo | first6 = TJ. | last7 = Jimenez | first7 = RE. | title = Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. | journal = Am J Surg Pathol | volume = 36 | issue = 3 | pages = 432-42 | month = Mar | year = 2012 | doi = 10.1097/PAS.0b013e31823fe49c | PMID = 22301493 }}</ref>
====Images====
<gallery>
Image:Urachal_carcinoma_-_very_low_mag.jpg | UC - very low mag. (WC)
Image:Urachal_carcinoma_-_low_mag.jpg | UC - low mag. (WC)
Image:Urachal_carcinoma_-_high_mag.jpg | UC - high mag. (WC)
</gallery>
 
===IHC===
Features:<ref name=pmid19252435>{{Cite journal  | last1 = Gopalan | first1 = A. | last2 = Sharp | first2 = DS. | last3 = Fine | first3 = SW. | last4 = Tickoo | first4 = SK. | last5 = Herr | first5 = HW. | last6 = Reuter | first6 = VE. | last7 = Olgac | first7 = S. | title = Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. | journal = Am J Surg Pathol | volume = 33 | issue = 5 | pages = 659-68 | month = May | year = 2009 | doi = 10.1097/PAS.0b013e31819aa4ae | PMID = 19252435 }}</ref>
*CK20 +ve.
*CK7 +ve/-ve.
*CK34betaE12 +ve/-ve.
*Beta-catenin -- usu cytoplasmic/membranous +ve.
 
Others:<ref name=pmid21572312>{{Cite journal  | last1 = Paner | first1 = GP. | last2 = McKenney | first2 = JK. | last3 = Barkan | first3 = GA. | last4 = Yao | first4 = JL. | last5 = Frankel | first5 = WL. | last6 = Sebo | first6 = TJ. | last7 = Shen | first7 = SS. | last8 = Jimenez | first8 = RE. | title = Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. | journal = Am J Surg Pathol | volume = 35 | issue = 6 | pages = 787-98 | month = Jun | year = 2011 | doi = 10.1097/PAS.0b013e3182189c11 | PMID = 21572312 }}</ref>
*p63 -ve (+ve in only 3%).
 
UC versus [[CRC]] -- not absolute but useful:
*CK34betaE12 +ve in UC (-ve in CRC).
*Beta-catenin -ve nuclei in UC (+ve nuclei in CRC).
 
===Sign out===
*The diagnosis is clinicopathologic; one needs imaging.<ref name=Ref_Amin2-143>{{Ref Amin|2-143}}</ref>


==Urinary bladder infarct==
==Urinary bladder infarct==

Revision as of 00:17, 6 December 2013

The urinary bladder stores urine until one has to go wee-wee.

It is commonly afflicted by cancer.

A well-know mimicker of cancer is malakoplakia.[1]

Normal

Microscopic

  • Muscularis mucosae - thin, discontinuous.
  • Fat - many be in lamina propria.

Note:

  • On TURBT - don't ever call T3.

Urinary bladder cancer

The most common type of cancer to affect the bladder is urothelial carcinoma. This is covered in the urothelium article.

Risk factors for bladder cancer SEX LIC:

  • Schistomsoma haematobium - esp. squamous cell carcinoma.[2]
  • EXtrophy of the bladder.
  • Lithiasis.
  • Indwelling catheter or chronic Inflammation.[2]
  • Cyclophosphamide.

DDx:

Squamous cell carcinoma of the urinary bladder

General

  • Strong association with Schistosoma haematobium.[2]
    • Common in areas with S. haematobium.
    • Uncommon in areas without S. haematobium.

Microscopic

Features:

Urachal carcinoma

Urinary bladder infarct

General

Microscopic

Features:[3]

  • Necrosis without liquefaction.
    • Outlines of cells visible.
    • No nuclei present.

Note:

  • Liquefaction implies an infectious etiology.[3]

Rhabdomyosarcoma

See also

References

  1. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Davis CJ (2006). "From the archives of the AFIP: Inflammatory and nonneoplastic bladder masses: radiologic-pathologic correlation". Radiographics 26 (6): 1847–68. doi:10.1148/rg.266065126. PMID 17102055.
  2. 2.0 2.1 2.2 Michaud, DS.. "Chronic inflammation and bladder cancer.". Urol Oncol 25 (3): 260-8. doi:10.1016/j.urolonc.2006.10.002. PMID 17483025.
  3. 3.0 3.1 3.2 Nino-Murcia, M.; Friedland, GW. (1988). "Bladder infarct.". Urol Radiol 9 (4): 234-6. PMID 3394185.
  4. Kryvenko, ON.; Epstein, JI. (Jun 2013). "Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.". J Urol 189 (6): 2083-6. doi:10.1016/j.juro.2012.12.005. PMID 23228381.